Table 3.
Multivariate model for worsening of at least two and three functional outcomes.
| Variable For WRS2 NTCP Model | Coeff | p-value | Odds Ratio(-95%CI,+95%CI) |
|---|---|---|---|
| Weekly integral dose (L·Gy/week, continuous variable) |
0.035 | 0.03 | 1.035 (-0.033,+0.034) |
| Treatment technique (IMRT/VMAT vs. 3DCRT) |
0.65 | 0.05 | 1.92 (-0.97,+1.95) |
| Diabetes (yes vs. no) |
-0.75 | 0.02 | 0.47 (-0.22,0.40) |
| Use of beta blockers (yes vs. no) |
-0.40 | 0.11 | 0.67 (-0.26,0.42) |
| Constant | -1.83 | ||
| Variable For WRS3 NTCP Model |
Coeff | p-value | Odds Ratio (-95%CI,+95%CI) |
| Weekly integral dose (L·Gy/week, continuous variable) |
0.036 | 0.07 | 1.037 (-0.033,+0.034) |
| Treatment technique (IMRT/VMAT vs. 3DCRT) |
0.89 | 0.08 | 2.44 (-1.56,+4.28) |
| Diabetes (yes vs. no) |
-0.98 | 0.03 | 0.38 (-0.22,0.52) |
| Constant | -2.92 |